intellicell biosciences inc
Frederick Frank CFA
Executive Advisor, IntelliCell BioSciences, Inc.
|Age||Total Calculated Compensation||This person is connected to 304 board members in 30 different organizations across 29 different industries.|
See Board Relationships
Mr. Frederick Frank, also known as Fred, CFA serves as the Managing Partner at Life Sciences Partners. Mr. Frank serves as an Advisor at Rose Ventures, Inc. He serves as a Principal Advisor of EGeen International Corporation. Mr. Frank has been an Executive Advisor at IntelliCell BioSciences, Inc. since May 2012. He is a Special Advisor to the Board at PanGenX, Inc. He has been Advisor of Chromatics Color Sciences International Inc. since December 1, 1997. He serves ...
460 Park AvenuePhone: 212-249-3050
New York, New York 10022
Board Members Memberships*
Vice Chairman and Vice Chairman of Global Healthcare Group
Member of Board of Managers
Independent Director, Chairman of Finance & Audit Committee and Member of Nominating & Governance Committee
Former Presiding Director, Member of Audit Committee, Member of Compensation Committee and Member of Executive Committee
Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Former Chairman and Member of Audit Committee
Chairman and Member of Audit Committee
Former Lead Director, Chairman of Nominating & Governance Committee, Member of Compensation Committee and Member of Audit Committee
Stanford Graduate School of Business
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Gil Van Bokkelen Ph.D.||Co-Founder, Chairman and Chief Executive Officer|
|Marc H. Hedrick M.D.||Chief Executive Officer, President, Director and Member of Executive Committee|
Cytori Therapeutics, Inc.
|Martin M. McGlynn||Chief Executive Officer, Director, Chief Executive Officer of Stemcells California Inc, President of Stemcells California Inc and Member of Strategic Transactions Committee|
|David J. Mazzo B.A (Hons), B.Sc. (Hons.), M.Sc., Ph.D.||Chief Executive Officer and Director|
|Mark R. Weinreb M.S.||Chairman, Chief Executive Officer and President|
BioRestorative Therapies, Inc.
|$360.0K||Compensation as of Fiscal Year 2014.|